Matthews C, Jenkins G, Hilfinger J, Davidson B
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242, USA.
Gene Ther. 1999 Sep;6(9):1558-64. doi: 10.1038/sj.gt.3300978.
In vivo gene transfer with recombinant adenovirus vectors can be hindered by the immunogenicity of the adenovirus capsid proteins. Previous work showed that formulation of the vector with biodegradable polymers such as poly-lactic-glycolic acid (PLGA), polyethylene glycol (PEG), or lipids, may shield the virus from inhibition by neutralizing antibodies. Formulation of adenovirus in PLGA microspheres also allowed for extended release in vitro. In experiments described here, we found that the surfactant used in the formation of the primary emulsion could significantly improve the overall yield of virus released. We also tested the effects of adding poly-L-lysine to adenovirus before encapsulation with PLGA. Our results show that although PLL did not effect the yield of virus encapsulated or released from the microspheres, it significantly improved the efficiency of gene transfer after release from the polymer.
重组腺病毒载体的体内基因转移可能会受到腺病毒衣壳蛋白免疫原性的阻碍。先前的研究表明,用可生物降解的聚合物(如聚乳酸-乙醇酸共聚物(PLGA)、聚乙二醇(PEG)或脂质)对载体进行配制,可能会通过中和抗体来保护病毒免受抑制。将腺病毒配制在PLGA微球中还能使其在体外实现缓释。在此处描述的实验中,我们发现用于形成初级乳液的表面活性剂能够显著提高释放的病毒的总产量。我们还测试了在将腺病毒用PLGA包封之前添加聚-L-赖氨酸的效果。我们的结果表明,虽然聚-L-赖氨酸对包封在微球中或从微球中释放的病毒产量没有影响,但它显著提高了从聚合物中释放后基因转移的效率。